Compare $BCLI vs $PASG | Chartloom

Compare

$BCLI vs $PASG

Brainstorm Cell Therapeutics Inc · Passage Bio Inc

BCLI

Brainstorm Cell Therapeutics Inc

PASG

Passage Bio Inc

Compare $BCLI vs $PASG

Comparing Brainstorm Cell Therapeutics Inc and Passage Bio Inc

BCLIBrainstorm Cell Therapeutics Inc

PASGPassage Bio Inc

BCLIBrainstorm Cell Therapeutics Inc

Market cap

$10M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

54.9%

52W performance

30.1%

FCF yield

-21.1%

PASGPassage Bio Inc

Market cap

$12M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-68.4%

52W performance

-55.4%

FCF yield

-282.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BCLI

PASG

Detailed metrics comparison

BCLI

Brainstorm Cell Therapeutics Inc

PASG

Passage Bio Inc

Market Cap

BCLI$10M

PASG$12M

Enterprise Value

BCLI$12M

PASG$-12M

Price

BCLI$0.95

PASG$3.69

P/E Ratio

BCLIN/A

PASGN/A

P/S Ratio

BCLI0.00x

PASG0.00x

EV/Sales

BCLI0.00x

PASG0.00x

EV/EBITDA

BCLI0.00x

PASG0.00x

P/B Ratio

BCLI7.31x

PASG2.98x

P/FCF Ratio

BCLIN/A

PASGN/A

EV/FCF

BCLI-5.29x

PASG0.37x

PEG Ratio

BCLIN/A

PASGN/A

Forward P/E (NTM)

BCLIN/A

PASGN/A

Forward P/S (NTM)

BCLIN/A

PASGN/A

Revenue (TTM)

BCLI$0

PASG$0

Revenue Growth (YoY)

BCLIN/A

PASGN/A

Forward Rev Growth

BCLI53.7%

PASG582.0%

Gross Margin (TTM)

BCLI0.0%

PASG0.0%

Operating Margin (TTM)

BCLI0.0%

PASG0.0%

EBITDA Margin (TTM)

BCLI0.0%

PASG0.0%

Net Margin (TTM)

BCLI0.0%

PASG0.0%

FCF Margin (TTM)

BCLIN/A

PASGN/A

Net Income (TTM)

BCLI$-7M

PASG$-36M

FCF (TTM)

BCLI$-2M

PASG$-34M

EPS (TTM)

BCLI-$0.61

PASG-$11.25

ROE (TTM)

BCLI-23636.0%

PASG-21859.0%

ROA (TTM)

BCLI-33822.0%

PASG-7292.0%

ROIC (TTM)

BCLI-23636.0%

PASG-21859.0%

Cash

BCLI$22K

PASG$24M

Debt

BCLI$1M

PASG$0

Net Cash/Debt

BCLI$-1M

PASG$24M

Current Ratio (TTM)

BCLI0.21x

PASG1.22x

Quick Ratio (TTM)

BCLI0.16x

PASG1.17x

Debt/Equity (TTM)

BCLI0.00x

PASG0.00x

Debt/Assets (TTM)

BCLI0.0%

PASG0.0%

Interest Coverage (TTM)

BCLIN/A

PASGN/A

Net Debt/EBITDA (TTM)

BCLI0.00x

PASG0.00x

Beta

BCLI0.39

PASG1.48

52W Performance

BCLI30.1%

PASG-55.4%

YTD Performance

BCLI54.9%

PASG-68.4%

% from 52W High

BCLI-43.8%

PASG-81.5%

% from 52W Low

BCLI106.9%

PASG12.2%

Asset Turnover (TTM)

BCLI0.00x

PASG0.00x

FCF Yield (TTM)

BCLI-21.1%

PASG-282.8%

Earnings Yield (TTM)

BCLI-64.2%

PASG-304.9%

Dividend Yield (TTM)

BCLIN/A

PASGN/A

Rule of 40

BCLI0.0

PASG0.0

EV/GP/RG

BCLIN/A

PASGN/A

Ticker research

View BCLI research View PASG research

Metric	BCLI Brainstorm Cell Therapeutics Inc	PASG Passage Bio Inc
Market & Valuation
Market Cap	$10M	$12M
Enterprise Value	$12M	$-12M
Price	$0.95	$3.69
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	7.31x	2.98x
P/FCF Ratio	N/A	N/A
EV/FCF	-5.29x	0.37x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	53.7%	582.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-7M	$-36M
FCF (TTM)	$-2M	$-34M
EPS (TTM)	-$0.61	-$11.25
ROE (TTM)	-23636.0%	-21859.0%
ROA (TTM)	-33822.0%	-7292.0%
ROIC (TTM)	-23636.0%	-21859.0%
Financial Health
Cash	$22K	$24M
Debt	$1M	$0
Net Cash/Debt	$-1M	$24M
Current Ratio (TTM)	0.21x	1.22x
Quick Ratio (TTM)	0.16x	1.17x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.39	1.48
52W Performance	30.1%	-55.4%
YTD Performance	54.9%	-68.4%
% from 52W High	-43.8%	-81.5%
% from 52W Low	106.9%	12.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-21.1%	-282.8%
Earnings Yield (TTM)	-64.2%	-304.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BCLI research	View PASG research

Valuation

P/S Ratio

BCLI

0.00x

PASG

0.00x

EV/FCF

BCLI

-5.29x

PASG

0.37x

Growth & revenue

Forward Revenue Growth

PASG

582.0%

BCLI

53.7%

Profitability & performance

Gross Margin

BCLI

0.0%

PASG

0.0%

ROE

PASG

-21859.0%

BCLI

-23636.0%

FCF Yield %

BCLI

-21.1%

PASG

-282.8%

52-Week Performance

BCLI

30.1%

PASG

-55.4%

Detailed metrics comparison

BCLI

Brainstorm Cell Therapeutics Inc

PASG

Passage Bio Inc

Market Cap

BCLI$10M

PASG$12M

Enterprise Value

BCLI$12M

PASG$-12M

Price

BCLI$0.95

PASG$3.69

P/E Ratio

BCLIN/A

PASGN/A

P/S Ratio

BCLI0.00x

PASG0.00x

EV/Sales

BCLI0.00x

PASG0.00x

EV/EBITDA

BCLI0.00x

PASG0.00x

P/B Ratio

BCLI7.31x

PASG2.98x

P/FCF Ratio

BCLIN/A

PASGN/A

EV/FCF

BCLI-5.29x

PASG0.37x

PEG Ratio

BCLIN/A

PASGN/A

Forward P/E (NTM)

BCLIN/A

PASGN/A

Forward P/S (NTM)

BCLIN/A

PASGN/A

Revenue (TTM)

BCLI$0

PASG$0

Revenue Growth (YoY)

BCLIN/A

PASGN/A

Forward Rev Growth

BCLI53.7%

PASG582.0%

Gross Margin (TTM)

BCLI0.0%

PASG0.0%

Operating Margin (TTM)

BCLI0.0%

PASG0.0%

EBITDA Margin (TTM)

BCLI0.0%

PASG0.0%

Net Margin (TTM)

BCLI0.0%

PASG0.0%

FCF Margin (TTM)

BCLIN/A

PASGN/A

Net Income (TTM)

BCLI$-7M

PASG$-36M

FCF (TTM)

BCLI$-2M

PASG$-34M

EPS (TTM)

BCLI-$0.61

PASG-$11.25

ROE (TTM)

BCLI-23636.0%

PASG-21859.0%

ROA (TTM)

BCLI-33822.0%

PASG-7292.0%

ROIC (TTM)

BCLI-23636.0%

PASG-21859.0%

Cash

BCLI$22K

PASG$24M

Debt

BCLI$1M

PASG$0

Net Cash/Debt

BCLI$-1M

PASG$24M

Current Ratio (TTM)

BCLI0.21x

PASG1.22x

Quick Ratio (TTM)

BCLI0.16x

PASG1.17x

Debt/Equity (TTM)

BCLI0.00x

PASG0.00x

Debt/Assets (TTM)

BCLI0.0%

PASG0.0%

Interest Coverage (TTM)

BCLIN/A

PASGN/A

Net Debt/EBITDA (TTM)

BCLI0.00x

PASG0.00x

Beta

BCLI0.39

PASG1.48

52W Performance

BCLI30.1%

PASG-55.4%

YTD Performance

BCLI54.9%

PASG-68.4%

% from 52W High

BCLI-43.8%

PASG-81.5%

% from 52W Low

BCLI106.9%

PASG12.2%

Asset Turnover (TTM)

BCLI0.00x

PASG0.00x

FCF Yield (TTM)

BCLI-21.1%

PASG-282.8%

Earnings Yield (TTM)

BCLI-64.2%

PASG-304.9%

Dividend Yield (TTM)

BCLIN/A

PASGN/A

Rule of 40

BCLI0.0

PASG0.0

EV/GP/RG

BCLIN/A

PASGN/A

Ticker research

View BCLI research View PASG research

Metric	BCLI Brainstorm Cell Therapeutics Inc	PASG Passage Bio Inc
Market & Valuation
Market Cap	$10M	$12M
Enterprise Value	$12M	$-12M
Price	$0.95	$3.69
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	7.31x	2.98x
P/FCF Ratio	N/A	N/A
EV/FCF	-5.29x	0.37x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	53.7%	582.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-7M	$-36M
FCF (TTM)	$-2M	$-34M
EPS (TTM)	-$0.61	-$11.25
ROE (TTM)	-23636.0%	-21859.0%
ROA (TTM)	-33822.0%	-7292.0%
ROIC (TTM)	-23636.0%	-21859.0%
Financial Health
Cash	$22K	$24M
Debt	$1M	$0
Net Cash/Debt	$-1M	$24M
Current Ratio (TTM)	0.21x	1.22x
Quick Ratio (TTM)	0.16x	1.17x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.39	1.48
52W Performance	30.1%	-55.4%
YTD Performance	54.9%	-68.4%
% from 52W High	-43.8%	-81.5%
% from 52W Low	106.9%	12.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-21.1%	-282.8%
Earnings Yield (TTM)	-64.2%	-304.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BCLI research	View PASG research